Skip to main content
Top

Drugs

Issue 18/2015

Content (11 Articles)

Acknowledgement to Referees

  • Acknowledgement to Referees

The Challenges of Interstitial Cystitis: Current Status and Future Prospects

  • Current Opinion

Samuel Belknap, Eric Blalock, Deborah Erickson

Disease-Modifying Drugs in Parkinson’s Disease

  • Leading Article

Ariane Park, Mark Stacy

Complicated Intra-Abdominal Infections: The Old Antimicrobials and the New Players

  • Review Article

Young R. Lee, Danni McMahan, Catherine McCall, Gregory K. Perry

Adalimumab: A Review in Chronic Plaque Psoriasis

  • Adis Drug Evaluation

Celeste B. Burness, Kate McKeage

Idarucizumab: First Global Approval

  • AdisInsight Report

Celeste B. Burness

Mepolizumab: First Global Approval

  • AdisInsight Report

Gillian M. Keating

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images